VT News

Lorcan Cranitch

Ask VT AI
View News Summary
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
  • Newsmax files antitrust lawsuit against Fox News, alleging illegal monopoly and exclusionary practices to stifle competition in the right-leaning pay TV news market.
  • Trump faces backlash for military flyover during Epstein victims' press conference, intensifying scrutiny on his ties to the disgraced financier.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
  • Newsmax files antitrust lawsuit against Fox News, alleging illegal monopoly and exclusionary practices to stifle competition in the right-leaning pay TV news market.
  • Trump faces backlash for military flyover during Epstein victims' press conference, intensifying scrutiny on his ties to the disgraced financier.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Lorcan Cranitch

Top Topics

Trending in U.S.

World

Sport